載入...
ISLET TRANSPLANTATION IN TYPE 1 DIABETICS USING AN IMMUNOSUPPRESSIVE PROTOCOL BASED ON THE ANTI-LFA-1 ANTIBODY EFALIZUMAB
The applicability of islet transplantation as treatment for type 1 diabetes is limited by renal and islet toxicities of currently available immunosuppressants. We describe a novel immunosuppressive regimen using the anti-leukocyte functional antigen-1 antibody efalizumab which permits long-term isle...
Na minha lista:
Main Authors: | , , , , , , , , , , , |
---|---|
格式: | Artigo |
語言: | Inglês |
出版: |
2010
|
主題: | |
在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2911648/ https://ncbi.nlm.nih.gov/pubmed/20659093 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1600-6143.2010.03073.x |
標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|